Answer
Aggrastat is not recommended with thrombolytic therapy given concurrently or less than 48 hours before Aggrastat because experience is insufficient and an increased risk of bleeding is suspected.
Sources for this answer
- Aggrastat 250 mcg/ml Concentrate for Solution for InfusionADVANZ Pharma · emc · SmPC §4.5 Interaction with other medicinal products · Version 16Document updated
Sources checked